Randomization to Endovascular Treatment Alone or Preceded by Systemic Thrombolysis With Tenecteplase in Ischemic Stroke

PHASE3RecruitingINTERVENTIONAL
Enrollment

398

Participants

Timeline

Start Date

May 27, 2022

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2027

Conditions
Stroke, IschemicStroke, Acute
Interventions
DRUG

Tenecteplase

Intravenous thrombolysis with tenecteplase 0.25mg/kg

DRUG

Placebo

Intravenous administration of placebo, matching the volume of tenecteplase 0.25mg/kg

Trial Locations (13)

90035000

RECRUITING

Hospital Moinhos de Vento, Porto Alegre

Unknown

RECRUITING

Hospital das Clínicas Botucatu, Botucatu

RECRUITING

Hospital de Base do Distrito Federal, Brasília

RECRUITING

Hospital das Clínicas da UFPR, Curitiba

RECRUITING

Hospital Geral de Fortaleza, Fortaleza

RECRUITING

Hospital de Clinicas de Porto Alegre, Porto Alegre

RECRUITING

Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto, Ribeirão Preto

RECRUITING

Hospital de Base de Rio Preto, São José do Rio Preto

RECRUITING

Hospital das Clínicas de São Paulo, São Paulo

RECRUITING

Hospital Sao Paulo, São Paulo

RECRUITING

Santa Casa de Misericordia de Sao Paulo, São Paulo

RECRUITING

Hospital Universitário de Uberlândia, Uberlândia

RECRUITING

Hospital Estadual Central, Vitória

Sponsors
All Listed Sponsors
collaborator

Ministry of Health, Brazil

OTHER_GOV

collaborator

Boehringer Ingelheim

INDUSTRY

collaborator

Medtronic

INDUSTRY

lead

Hospital Moinhos de Vento

OTHER

NCT05199194 - Randomization to Endovascular Treatment Alone or Preceded by Systemic Thrombolysis With Tenecteplase in Ischemic Stroke | Biotech Hunter | Biotech Hunter